arrow
N

Naomi Guppy

The Institute of Cancer Research
H指数:20
被引数:1,176

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

IAP antagonist tolinapant (ASTX660) in combination with pembrolizumab in advanced solid tumors: a phase I trial

IAP拮抗剂托利那潘特(ASTX660)联合帕博利珠单抗治疗晚期实体瘤:一项I期临床试验

2026-09-300
OA
Co-occurrence of transcriptionally distinct persister cell states underpins neoadjuvant therapy resistance in triple‑negative breast cancer

转录异质性持久细胞状态的共发生是三阴性乳腺癌新辅助治疗耐药的基础

2026-04-090
OA
Necroptosis in both tumour and stromal compartments determines responsiveness to immunogenic cell death-based immunotherapy

肿瘤和基质区室中的坏死性凋亡决定了对免疫原性细胞死亡为基础的免疫治疗的反应性

2026-03-010
OA
SPP1 is required for maintaining mesenchymal cell fate in pancreatic cancer

SPP1对于维持胰腺癌的间充质细胞命运是必需的。

Nature
IF48.5
2025-09-240
OA
Anti-EGFR Antibody-Drug Conjugate Carrying an Inhibitor Targeting CDK Restricts Triple-Negative Breast Cancer Growth
2024-05-216
OAAI
SF3B1 hotspot mutations confer sensitivity to PARP inhibition through a defective replication stress response
2023-12-010
PRE
SF3B1 hotspot mutations confer sensitivity to PARP inhibition by eliciting a defective replication stress response
2023-07-3118
OAAI
Mutations in the RNA Splicing Factor SF3B1 drive endocrine therapy resistance and confer a targetable replication stress response defect through PARP inhibition
2023-03-010
PRE
Ubiquitylation of MLKL at lysine 219 positively regulates necroptosis-induced tissue injury and pathogen clearance
2021-06-0752
OAAI
3D Functional Genomics Screens Identify CREBBP as a Targetable Driver in Aggressive Triple-Negative Breast Cancer
2021-02-1510
OA
RIPK1-mediated immunogenic cell death promotes anti-tumour immunity against soft-tissue sarcoma

RIPK1-mediated免疫原性细胞死亡促进对软组织肉瘤的抗肿瘤免疫

2020-05-1824
OAAI
ARID1A influences HDAC1/BRD4 activity, intrinsic proliferative capacity and breast cancer treatment response (vol 87, pg 925, 2020)
2020-01-315
OAAI
ARID1A influences HDAC1/BRD4 activity, intrinsic proliferative capacity and breast cancer treatment response
2020-01-06120
OAAI
LOSS OF BAP1 FUNCTION LEADS TO TRAIL SENSITIVITY IN MESOTHELIOMA
THORAX
IF7.7
2018-11-161
PREAI